Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease (Q46641193)

23 December 2017

title

Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease (English)

1 reference

23 December 2017

0 references

Wei Liu

1

1 reference

23 December 2017

Weiwei Feng

2

1 reference

23 December 2017

Fang Wang

3

1 reference

23 December 2017

Weimin Li

4

1 reference

23 December 2017

Cheng Gao

5

1 reference

23 December 2017

Baoguo Zhou

6

1 reference

23 December 2017

Manling Ma

7

1 reference

23 December 2017

publication date

7 March 2008

1 reference

23 December 2017

Experimental and Molecular Pathology

published in

1 reference

23 December 2017

volume

84

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

213-217

1 reference

23 December 2017

Lung tissue hydrolysates: studies of the optimum conditions for the spectrophotometric determination of hydroxyproline

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Osteoprotegerin is not associated with angiographic coronary calcification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Increased circulating concentrations and augmented myocardial extraction of osteoprotegerin in heart failure due to left ventricular pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Initially elevated osteoprotegerin serum levels may predict a perioperative myocardial lesion in patients undergoing coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Effects of adenovirus-mediated gene transfer of ICOSIg and CTLA4Ig fusion protein on experimental autoimmune myocarditis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Role for osteoprotegerin in rheumatoid inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Increased osteoprotegerin serum levels in men with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Matrix metalloproteinases: regulation and dysregulation in the failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Cardiac interstitium in health and disease: the fibrillar collagen network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Upregulation of CD4+CD25+ T lymphocyte by adenovirus-mediated gene transfer of CTLA4Ig fusion protein in experimental autoimmune myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

Regulation of osteoclast protease expression by RANKL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

A role for T lymphocytes in mediating cardiac diastolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2008.02.004

10.1016/J.YEXMP.2008.02.004

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017